{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:31:13Z","timestamp":1793399473767,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi della Campania Luigi Vanvitelli","id":[{"id":"https:\/\/ror.org\/02kqnpp86","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the relationship between late onset hypogonadism (LOH) with inflammation and lower-limb vascular complications in men with type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-centre, retrospective observational study included men with T2D who underwent hormonal evaluation between 2020 and 2024. LOH was diagnosed according to SIAMS\/SIE and EAU guidelines and participants were classified as hypogonadal or eugonadal. Demographic, metabolic, inflammatory, and haematological parameters were collected. Lower-limb vascular complications, including peripheral artery disease (PAD), diabetic foot ulcer (DFU), osteomyelitis and amputation, were assessed. Logistic regression analyses were performed to evaluate the association between testosterone (T) levels and vascular complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study population included 155 men, with a prevalence of LOH of 50.3%. Hypogonadal men showed significantly lower haemoglobin and haematocrit levels and higher inflammatory markers compared with eugonadal subjects. Microvascular complications did not differ between groups, except for a higher prevalence of DFU in hypogonadal men. Conversely, macrovascular lower-limb complications were more frequent in men with LOH, including PAD, osteomyelitis, and amputation. Higher T levels were associated with a reduced number of these outcomes. After multivariable adjustment, T levels remained independently associated with the risk of PAD and lower limb amputation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In our cohort of men with T2D, hypogonadism is associated with an increased burden of macrovascular and lower limb complications. Lower T levels were independently associated with PAD and amputation, supporting hypogonadism as a marker of vascular impairment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40618-026-02967-4","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:48:30Z","timestamp":1782474510000},"page":"3531-3539","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Late-onset hypogonadism and lower limb vascular complications in men with type 2 diabetes: an observational study in a tertiary care centre"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1308-0769","authenticated-orcid":false,"given":"Rita","family":"Matrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-2022","authenticated-orcid":false,"given":"Paola","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6459-5854","authenticated-orcid":false,"given":"Miriam","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pontillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Porcellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tomasuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7628-2226","authenticated-orcid":false,"given":"Lorenzo","family":"Scappaticcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ida","family":"Maiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-321X","authenticated-orcid":false,"given":"Giuseppe","family":"Bellastella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-5154","authenticated-orcid":false,"given":"Katherine","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2967_CR1","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","volume":"383","author":"S Basaria","year":"2014","unstructured":"Basaria S (2014) Male hypogonadism. Lancet 383:1250\u20131263. https:\/\/doi.org\/10.1016\/S0140-6736(13)61126-5","journal-title":"Lancet"},{"key":"2967_CR2","unstructured":"Sizar O, Leslie SW, Schwartz J (2025) Male Hypogonadism"},{"key":"2967_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41443-021-00471-2","volume":"34","author":"JM Auerbach","year":"2022","unstructured":"Auerbach JM, Moghalu OI, Das R, Horns J, Campbell A, Hotaling J et al (2022) Evaluating incidence, prevalence, and treatment trends in adult men with hypogonadism in the United States. Int J Impot Res 34:762\u2013768. https:\/\/doi.org\/10.1038\/s41443-021-00471-2","journal-title":"Int J Impot Res"},{"key":"2967_CR4","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P (2004) Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes. J Clin Endocrinol Metab 89:5462\u20135468. https:\/\/doi.org\/10.1210\/jc.2004-0804","journal-title":"J Clin Endocrinol Metab"},{"key":"2967_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1089\/andro.2022.0019","volume":"3","author":"P Dandona","year":"2022","unstructured":"Dandona P, Dhindsa S, Ghanim H (2022) Hypogonadotropic Hypogonadism in Diabesity: Pathogenic Factors and Therapeutic Implications. Androg Clin Res Ther 3:214\u2013216. https:\/\/doi.org\/10.1089\/andro.2022.0019","journal-title":"Androg Clin Res Ther"},{"key":"2967_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/j.1439-0272.2011.01262.x","volume":"44","author":"M Arafa","year":"2012","unstructured":"Arafa M, Zohdy W, Aboulsoud S, Shamloul R (2012) Prevalence of late-onset hypogonadism in men with type 2 diabetes mellitus. Andrologia 44:756\u2013763. https:\/\/doi.org\/10.1111\/j.1439-0272.2011.01262.x","journal-title":"Andrologia"},{"key":"2967_CR7","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1210\/jc.2010-2724","volume":"96","author":"P Dandona","year":"2011","unstructured":"Dandona P, Dhindsa S, Update (2011) Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity. J Clin Endocrinol Metab 96:2643\u20132651. https:\/\/doi.org\/10.1210\/jc.2010-2724","journal-title":"J Clin Endocrinol Metab"},{"key":"2967_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41367-019-0008-2","volume":"9","author":"G Bellastella","year":"2019","unstructured":"Bellastella G, Menafra D, Puliani G, Colao A, Savastano S (2019) How much does obesity affect the male reproductive function? Int J Obes Suppl 9:50\u201364. https:\/\/doi.org\/10.1038\/s41367-019-0008-2","journal-title":"Int J Obes Suppl"},{"key":"2967_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/13685538.2016.1154523","volume":"19","author":"R Blaya","year":"2016","unstructured":"Blaya R, Thomaz LDGR, Guilhermano F, Paludo A, de O, Rhoden L, Halmenschlager G et al (2016) Total testosterone levels are correlated to metabolic syndrome components. Aging Male 19:85\u201389. https:\/\/doi.org\/10.3109\/13685538.2016.1154523","journal-title":"Aging Male"},{"key":"2967_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/cen.12092","volume":"78","author":"SA Saboor Aftab","year":"2013","unstructured":"Saboor Aftab SA, Kumar S, Barber TM (2013) The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism. Clin Endocrinol (Oxf) 78:330\u2013337. https:\/\/doi.org\/10.1111\/cen.12092","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2967_CR11","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.2337\/dc13-0637","volume":"36","author":"G Bellastella","year":"2013","unstructured":"Bellastella G, Maiorino MI, Olita L, De Bellis A, Giugliano D, Esposito K (2013) Anti-pituitary antibodies and hypogonadotropic hypogonadism in type 2 diabetes: in search of a role. Diabetes Care 36:e116\u2013e117. https:\/\/doi.org\/10.2337\/dc13-0637","journal-title":"Diabetes Care"},{"key":"2967_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/andr.12433","volume":"6","author":"A Herrero","year":"2018","unstructured":"Herrero A, Marcos M, Galindo P, Miralles JM, Corrales JJ (2018) Clinical and biochemical correlates of male hypogonadism in type 2 diabetes. Andrology 6:58\u201363. https:\/\/doi.org\/10.1111\/andr.12433","journal-title":"Andrology"},{"key":"2967_CR13","doi-asserted-by":"publisher","first-page":"e17823","DOI":"10.7717\/peerj.17823","volume":"12","author":"T Zhuo","year":"2024","unstructured":"Zhuo T, Yao X, Mei Y, Yang H, Maimaitiyiming A, Huang X et al (2024) Effect of metabolic syndrome on testosterone levels in patients with metastatic prostate cancer: a real-world retrospective study. PeerJ 12:e17823. https:\/\/doi.org\/10.7717\/peerj.17823","journal-title":"PeerJ"},{"key":"2967_CR14","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2337\/dc06-1426","volume":"30","author":"D Kapoor","year":"2007","unstructured":"Kapoor D, Aldred H, Clark S, Channer KS, Jones TH (2007) Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes. Diabetes Care 30:911\u2013917. https:\/\/doi.org\/10.2337\/dc06-1426","journal-title":"Diabetes Care"},{"key":"2967_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/humupd\/dmx033","volume":"24","author":"CC Maresch","year":"2018","unstructured":"Maresch CC, Stute DC, Alves MG, Oliveira PF, de Kretser DM, Linn T (2018) Diabetes-induced hyperglycemia impairs male reproductive function: a systematic review. Hum Reprod Update 24:86\u2013105. https:\/\/doi.org\/10.1093\/humupd\/dmx033","journal-title":"Hum Reprod Update"},{"key":"2967_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/ijem.ijem_239_21","volume":"25","author":"SK Gangwar","year":"2021","unstructured":"Gangwar SK, Verma SK, Modi S (2021) Frequency and Correlates of Hypogonadism in Adult Males with Type 2 Diabetes Mellitus. Indian J Endocrinol Metab 25:320\u2013325. https:\/\/doi.org\/10.4103\/ijem.ijem_239_21","journal-title":"Indian J Endocrinol Metab"},{"key":"2967_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4038\/sjdem.v6i1.7300","volume":"6","author":"S Bajaj","year":"2016","unstructured":"Bajaj S, Srivastava A, Varma A, Tiwari A (2016) Serum testosterone in males with newly diagnosed type 2 diabetes mellitus and microvascular complications. Sri Lanka J Diabetes Endocrinol Metabolism 6:18. https:\/\/doi.org\/10.4038\/sjdem.v6i1.7300","journal-title":"Sri Lanka J Diabetes Endocrinol Metabolism"},{"key":"2967_CR18","doi-asserted-by":"publisher","unstructured":"Raza MT, Sharif S, Khan ZA, Naz S, Mushtaq S, Umer A (2019) Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease. Cureus. https:\/\/doi.org\/10.7759\/cureus.6500","DOI":"10.7759\/cureus.6500"},{"key":"2967_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/2230-8210.195999","volume":"21","author":"S Madhu","year":"2017","unstructured":"Madhu S, Aslam M, Aiman A, Siddiqui A, Dwivedi S (2017) Prevalence of hypogonadism in male Type 2 diabetes mellitus patients with and without coronary artery disease. Indian J Endocrinol Metab 21:31. https:\/\/doi.org\/10.4103\/2230-8210.195999","journal-title":"Indian J Endocrinol Metab"},{"key":"2967_CR20","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1210\/jc.2014-2585","volume":"99","author":"JM Farias","year":"2014","unstructured":"Farias JM, Tinetti M, Khoury M, Umpierrez GE (2014) Low Testosterone Concentration and Atherosclerotic Disease Markers in Male Patients With Type 2 Diabetes. J Clin Endocrinol Metab 99:4698\u20134703. https:\/\/doi.org\/10.1210\/jc.2014-2585","journal-title":"J Clin Endocrinol Metab"},{"key":"2967_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12933-019-0901-6","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang C, Zhang W, Wang Y, Wan H, Chen Y, Xia F et al (2019) Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study. Cardiovasc Diabetol 18:97. https:\/\/doi.org\/10.1186\/s12933-019-0901-6","journal-title":"Cardiovasc Diabetol"},{"key":"2967_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/sxmrev\/qead031","volume":"11","author":"AM Traish","year":"2023","unstructured":"Traish AM (2023) Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy \u2013 a narrative review. Sex Med Rev 11:384\u2013394. https:\/\/doi.org\/10.1093\/sxmrev\/qead031","journal-title":"Sex Med Rev"},{"key":"2967_CR23","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc26-S002","volume":"49","author":"M Bajaj","year":"2026","unstructured":"Bajaj M, McCoy RG, Balapattabi K, Bannuru RR, Bellini NJ, Bennett AK et al (2026) 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026. Diabetes Care 49:S27\u201349. https:\/\/doi.org\/10.2337\/dc26-S002","journal-title":"Diabetes Care"},{"key":"2967_CR24","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s40618-022-01859-7","volume":"45","author":"AM Isidori","year":"2022","unstructured":"Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F et al (2022) Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest 45:2385\u20132403. https:\/\/doi.org\/10.1007\/s40618-022-01859-7","journal-title":"J Endocrinol Invest"},{"key":"2967_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.eururo.2025.04.010","volume":"88","author":"A Salonia","year":"2025","unstructured":"Salonia A, Capogrosso P, Boeri L, Cocci A, Corona G, Dinkelman-Smit M et al (2025) European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie\u2019s Disease. Eur Urol 88:76\u2013102. https:\/\/doi.org\/10.1016\/j.eururo.2025.04.010","journal-title":"Eur Urol"},{"key":"2967_CR26","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen A, Verdonck L, Kaufman JM (1999) A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum. J Clin Endocrinol Metab 84:3666\u20133672. https:\/\/doi.org\/10.1210\/jcem.84.10.6079","journal-title":"J Clin Endocrinol Metab"},{"key":"2967_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/13685530802389628","volume":"12","author":"C Wang","year":"2009","unstructured":"Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ et al (2009) ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 12:5\u201312. https:\/\/doi.org\/10.1080\/13685530802389628","journal-title":"Aging Male"},{"key":"2967_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/13685538.2018.1482487","volume":"22","author":"N-V Mohamad","year":"2019","unstructured":"Mohamad N-V, Wong SK, Wan Hasan WN, Jolly JJ, Nur-Farhana MF, Ima-Nirwana S et al (2019) The relationship between circulating testosterone and inflammatory cytokines in men. Aging Male 22:129\u2013140. https:\/\/doi.org\/10.1080\/13685538.2018.1482487","journal-title":"Aging Male"},{"key":"2967_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3390\/jcm7120549","volume":"7","author":"A Traish","year":"2018","unstructured":"Traish A, Bolanos J, Nair S, Saad F, Morgentaler A (2018) Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence. J Clin Med 7:549. https:\/\/doi.org\/10.3390\/jcm7120549","journal-title":"J Clin Med"},{"key":"2967_CR30","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.pcd.2023.05.005","volume":"17","author":"J Singh","year":"2023","unstructured":"Singh J, Sahoo AK, Swain J, Mangaraj S, Kanwar JB, Manglunia A (2023) Assessment of hypogonadism and its determinants among adult men with type 2 diabetes mellitus. Prim Care Diabetes 17:348\u2013353. https:\/\/doi.org\/10.1016\/j.pcd.2023.05.005","journal-title":"Prim Care Diabetes"},{"key":"2967_CR31","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.3390\/ijms23073535","volume":"23","author":"B Barone","year":"2022","unstructured":"Barone B, Napolitano L, Abate M, Cirillo L, Reccia P, Passaro F et al (2022) The Role of Testosterone in the Elderly: What Do We Know? Int J Mol Sci 23:3535. https:\/\/doi.org\/10.3390\/ijms23073535","journal-title":"Int J Mol Sci"},{"key":"2967_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s42000-024-00587-2","volume":"23","author":"N Theodorakis","year":"2024","unstructured":"Theodorakis N, Feretzakis G, Vamvakou G, Verykios VS, Polymeris A, Nikolaou M (2024) Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives. Hormones 23:801\u2013817. https:\/\/doi.org\/10.1007\/s42000-024-00587-2","journal-title":"Hormones"},{"key":"2967_CR33","doi-asserted-by":"publisher","unstructured":"Chen B-T, Tsai P-J, Jiann B-P Association of total testosterone levels with cardiometabolic diseases in men with erectile dysfunction. Sex Med 2024;12. https:\/\/doi.org\/10.1093\/sexmed\/qfae089","DOI":"10.1093\/sexmed\/qfae089"},{"key":"2967_CR34","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1210\/jc.2011-1137","volume":"96","author":"AB Araujo","year":"2011","unstructured":"Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA (2011) Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 96:3007\u20133019. https:\/\/doi.org\/10.1210\/jc.2011-1137","journal-title":"J Clin Endocrinol Metab"},{"key":"2967_CR35","doi-asserted-by":"publisher","unstructured":"Oguz A, Sahin M, Ulgen C, Uyan M, Gul K Overt hypogonadism is a cardiovascular risk factor in type 2 diabetic males: An observational study. Andrologia 2022;54. https:\/\/doi.org\/10.1111\/and.14271","DOI":"10.1111\/and.14271"},{"key":"2967_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jsxmed\/qdad025","volume":"20","author":"CA Carto","year":"2023","unstructured":"Carto CA, Gurayah AA, Arbelaez MCS, Grewal MR, Kohn T, Ramasamy R (2023) Association between comorbidities and longitudinal changes in total testosterone among men from the Baltimore Longitudinal Study of Aging. J Sex Med 20:605\u2013611. https:\/\/doi.org\/10.1093\/jsxmed\/qdad025","journal-title":"J Sex Med"},{"key":"2967_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10522-022-10002-1","volume":"24","author":"JM Ketchem","year":"2023","unstructured":"Ketchem JM, Bowman EJ, Isales CM (2023) Male sex hormones, aging, and inflammation. Biogerontology 24:1\u201325. https:\/\/doi.org\/10.1007\/s10522-022-10002-1","journal-title":"Biogerontology"},{"key":"2967_CR38","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s11357-024-01293-y","volume":"47","author":"LE DuBose","year":"2024","unstructured":"DuBose LE, Babcock MC, Kohrt WM, Stauffer BL, Hildreth KL, Walker J et al (2024) Gonadal status modulates large elastic artery stiffness in healthy middle-aged and older men. Geroscience 47:3277\u20133289. https:\/\/doi.org\/10.1007\/s11357-024-01293-y","journal-title":"Geroscience"},{"key":"2967_CR39","doi-asserted-by":"publisher","first-page":"E234","DOI":"10.1152\/ajpendo.00059.2005","volume":"290","author":"H Hougaku","year":"2006","unstructured":"Hougaku H, Fleg JL, Najjar SS, Lakatta EG, Harman SM, Blackman MR et al (2006) Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements. Am J Physiology-Endocrinology Metabolism 290:E234\u2013E242. https:\/\/doi.org\/10.1152\/ajpendo.00059.2005","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"2967_CR40","doi-asserted-by":"publisher","first-page":"H115","DOI":"10.1152\/ajpheart.00046.2011","volume":"302","author":"V Deenadayalu","year":"2012","unstructured":"Deenadayalu V, Puttabyatappa Y, Liu AT, Stallone JN, White RE (2012) Testosterone-induced relaxation of coronary arteries: activation of BK Ca channels via the cGMP-dependent protein kinase. Am J Physiol Heart Circ Physiol 302:H115\u2013H123. https:\/\/doi.org\/10.1152\/ajpheart.00046.2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2967_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.beem.2010.07.002","volume":"25","author":"G Corona","year":"2011","unstructured":"Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M (2011) Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 25:337\u2013353. https:\/\/doi.org\/10.1016\/j.beem.2010.07.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2967_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1139\/O07-011","volume":"85","author":"H Jin","year":"2007","unstructured":"Jin H, Lin J, Fu L, Mei Y-F, Peng G, Tan X et al (2007) Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells. Biochem Cell Biol 85:246\u2013251. https:\/\/doi.org\/10.1139\/O07-011","journal-title":"Biochem Cell Biol"},{"key":"2967_CR43","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0026-0495(97)90232-8","volume":"46","author":"G De Pergola","year":"1997","unstructured":"De Pergola G, De Mitrio V, Sciaraffia M, Pannaccuilli N, Minenna A, Giorgino F et al (1997) Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men. Metabolism 46:1287\u20131293. https:\/\/doi.org\/10.1016\/S0026-0495(97)90232-8","journal-title":"Metabolism"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02967-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02967-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02967-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:01:36Z","timestamp":1793397696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02967-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["2967"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02967-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Maria Ida Maiorino has given lectures for Novo Nordisk, Eli Lilly, and Sanofi. Katherine Esposito received a consultancy fee from Eli Lilly and has given lectures for Eli Lilly, Sanofi, Novo Nordisk, Roche, Bayer, and Lifescan. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the Human Research Ethics Committee at the AOU University of Campania \u201cLuigi Vanvitelli\u201d (Naples, Italy) in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from each study participant.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}